Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base
- PMID: 17416855
- DOI: 10.1200/JCO.2006.08.8310
Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base
Abstract
Purpose: This study examines the demographics, presentation, and outcomes of children and teenagers with melanoma using a US hospital-based oncology database.
Patients and methods: Data from the National Cancer Data Base from 1985 through 2003 were examined for demographics, presentation, and survival of patients aged 1 to 19 years, as well as a comparison group of patients aged 20 to 24 years. Two-sided linear and Pearson chi2 tests were calculated to examine associations. Proportions were compared using two-sided z tests. Five-year overall observed survival was evaluated using the Kaplan-Meier method and the log-rank test. Cox proportional hazards regression was used to estimate risk of mortality.
Results: Of 3,158 patients aged 1 to 19 years, 96.3% had cutaneous melanoma, 3.0% had ocular melanoma, and 0.7% had an unknown primary tumor. Cutaneous melanoma in patients aged 1 to 19 years was more common in girls (55.5%) and patients older than 10 years (90.5%). The demographics and presentation of cutaneous melanoma were age related; younger children were significantly more likely to be nonwhite and male and more likely to present with a head and neck primary tumors and with regional or distant metastases (linear chi2, P < .001 for sex, race, and extent of disease). Poorer survival was associated with higher stage and younger age. In contrast to patients aged 20 to 24 years, survival was not related to thickness in patients aged 1 to 19 years with localized invasive melanoma.
Conclusion: Melanoma in children and teenagers differs from melanoma in young adults in demographics, presentation, and survival. Further investigation is warranted to elucidate possible biologic correlates of the unique aspects of melanoma in children and teenagers.
Similar articles
-
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.Br J Dermatol. 2006 Oct;155(4):771-7. doi: 10.1111/j.1365-2133.2006.07455.x. Br J Dermatol. 2006. PMID: 16965427
-
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.Cancer. 2007 Aug 1;110(3):614-24. doi: 10.1002/cncr.22818. Cancer. 2007. PMID: 17577228
-
Conjunctival melanoma in the Netherlands: a nationwide study.Invest Ophthalmol Vis Sci. 2005 Jan;46(1):75-82. doi: 10.1167/iovs.04-0344. Invest Ophthalmol Vis Sci. 2005. PMID: 15623757
-
Differences in malignant melanoma between children and adolescents. A 35-year epidemiological study.Arch Dermatol. 1997 Mar;133(3):295-7. Arch Dermatol. 1997. PMID: 9080889 Review.
-
Incidence, mortality and survival in cutaneous melanoma.J Plast Reconstr Aesthet Surg. 2007;60(1):32-40. doi: 10.1016/j.bjps.2006.05.008. Epub 2006 Jul 7. J Plast Reconstr Aesthet Surg. 2007. PMID: 17126264 Review.
Cited by
-
Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.Pediatr Surg Int. 2024 Mar 5;40(1):68. doi: 10.1007/s00383-024-05646-8. Pediatr Surg Int. 2024. PMID: 38441654 Free PMC article.
-
Pediatric Melanoma Arising in a Background of Melanocytic Nevi.Indian Dermatol Online J. 2023 Dec 22;15(1):89-91. doi: 10.4103/idoj.idoj_208_23. eCollection 2024 Jan-Feb. Indian Dermatol Online J. 2023. PMID: 38283032 Free PMC article.
-
Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results.Diagnostics (Basel). 2023 Jul 15;13(14):2380. doi: 10.3390/diagnostics13142380. Diagnostics (Basel). 2023. PMID: 37510125 Free PMC article.
-
The roles of different forms of IL-15 in human melanoma progression.Front Immunol. 2023 Jun 2;14:1183668. doi: 10.3389/fimmu.2023.1183668. eCollection 2023. Front Immunol. 2023. PMID: 37334356 Free PMC article.
-
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.Front Med (Lausanne). 2023 Jan 23;10:1117816. doi: 10.3389/fmed.2023.1117816. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36756176 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical